GEP NAMED AS A LEADER IN SUPPLY CHAIN PLATFORMS EVALUATION, RECEIVES HIGHEST SCORE POSSIBLE IN INNOVATION CRITERION
GEP recognized for its investments in AI-native architecture, agentic AI, and autonomous decision-making supplier networks Recognition follows recent leadership positions from Gartner, IDC and The Hackett Group across procurement, direct spend and...
RingConn Gen 3 Smart Ring Drew Attention at IFA 2026
BERLIN, Sept. 23, 2026 /PRNewswire/ -- RingConn showcased its latest Gen 3 Smart Ring at IFA 2026 in Berlin, presenting the smart ring across multiple locations throughout the show, including high-visibility area near the north entrance. The product...
Qure.ai's Clinical Decision Support System Aira Among World's First to Win Class IIb CE Certification
Built for frontline primary care in emerging economies, Aira is the first AI-powered clinical decision support system (CDSS) to combine documentation, workflow automation and analysis of patient EHR data with clinical decision-making under a single...
OCI N.V. statement regarding an open letter from shareholders
AMSTERDAM, Sept. 17, 2026 /PRNewswire/ -- OCI Global N.V. ("OCI" or the "Company") (Euronext: OCI) confirms that on 16 September 2026 it received from Oceanwood Capital Management LLP the attached open letter, written on behalf of a group of three...
FUJIFILM Business Innovation Celebrates 39 Award-Winning Entries at the Innovation Print Awards 2026 Asia-Pacific & Japan
TOKYO, Sept. 16, 2026 /PRNewswire/ -- FUJIFILM Business Innovation announces today the winners of the Innovation Print Awards 2026 Asia-Pacific & Japan (hereafter: IPA 2026 APJ) which celebrates creativity and technical excellence in production...
The Generation Essential Group's Receipt of NYSE Letter Regarding Class A Ordinary Shares Trading Price
NEW YORK and LONDON, Sept. 12, 2026 /PRNewswire/ -- The Generation Essentials Group (NYSE: TGE; LSE: TGE) ("TGE" or the "Company"), today announced that it has received a letter from the New York Stock Exchange (the "NYSE"), notifying the Company...
Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo
NEW YORK and SUZHOU, China, Sept. 8, 2026 /PRNewswire/ -- Accro Bioscience (Suzhou) Limited ("Accro") today announced that Shanghai Fosun Pharmaceutical Industrial Development Company Limited ("Fosun Pharma Industrial"), a subsidiary of its partner...
Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that it has recently received clearance from the U.S. Food and...
European Approval for Production Organisation Dutch Flying Car Company PAL-V
RAAMSDONKSVEER, Netherlands, Sept. 7, 2026 /PRNewswire/ -- Dutch company PAL-V has obtained its European Production Organisation Approval (POA). With this milestone, PAL-V now holds both the automotive and aviation production approvals required to...
China's Personalized mRNA Cancer Therapy Sector Accelerates: How Far Is It From a "DeepSeek Moment"?
BEIJING, Aug. 21, 2026 /PRNewswire/ -- Personalized mRNA cancer therapy has recently reached an important milestone. An international Phase 3 study in high-risk melanoma reported positive results, further supporting the clinical potential of...